Back
NewLake Capital Partners Vs. Moderna Industry Stock Comparison
Buy
72
NLCP
NewLake Capital Partners
Last Price:
20.20
Seasonality Move:
-7.14%
Sell
31
MRNA
Moderna
Last Price:
133.37
Seasonality Move:
26.69%
Buy
72
NewLake Capital Partners (NLCP)
is a Buy
Is NewLake Capital Partners a Buy, Sell or Hold?
- The current NewLake Capital Partners [NLCP] share price is $20.20. The Score for NLCP is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- NLCP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Moderna (MRNA)
is a Sell
Is Moderna a Buy, Sell or Hold?
- The current Moderna [MRNA] share price is $133.40. The Score for MRNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- MRNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NLCP Stock Price Chart
What is NewLake Capital Partners's stock price today?
-
The NewLake Capital Partners share price today is $20.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLCP is experiencing slight selling pressure.
MRNA Stock Price Chart
NLCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 60.26 | Buy |
| Chaikin Money Flow: | -889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.1 - 20.16) | Buy |
| Bollinger Bands (100): | (16.72 - 19.76) | Buy |
MRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.75 | Buy |
| Relative Strength Index (14 RSI): | 42.89 | Sell |
| Chaikin Money Flow: | -2093001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (136.94 - 156.02) | Sell |
| Bollinger Bands (100): | (93.99 - 135.65) | Buy |
NLCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.79 | Buy |
| 20-day SMA: | 19.46 | Buy |
| 50-day SMA: | 19.38 | Buy |
| 200-day SMA: | 16.22 | Buy |
| 8-day EMA: | 19.89 | Buy |
| 20-day EMA: | 19.67 | Buy |
| 50-day EMA: | 19.26 | Buy |
| 200-day EMA: | 17.1 | Buy |
MRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.03 | Sell |
| 20-day SMA: | 147.42 | Sell |
| 50-day SMA: | 129.92 | Buy |
| 200-day SMA: | 103.34 | Buy |
| 8-day EMA: | 138.83 | Sell |
| 20-day EMA: | 141.31 | Sell |
| 50-day EMA: | 132.6 | Buy |
| 200-day EMA: | 115.85 | Buy |
NewLake Capital Partners Earnings Growth & NLCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.00 per share.
Moderna Earnings Growth & MRNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.94 per share, a decrease next quarter of $1.70 per share, an increase this year of $6.46 per share, and an increase next year of $1.85 per share.
NewLake Capital Partners Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Moderna Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||